2021
DOI: 10.18410/jebmh/2021/203
|View full text |Cite
|
Sign up to set email alerts
|

How Does Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) Hold Up in Predicting Adverse Outcomes and Prognosis among Patients with Chronic Liver Disease Compared to Other Liver Scoring Systems?

Abstract: BACKGROUND Chronic liver disease is the progressive destruction of liver for 6 months thereby impairing clotting factor formation, bile metabolism, and protein synthesis. ChildPugh-Turcotte (CTP) score, model for end-stage liver disease (MELD) and MELD– sodium (Na) are well established calculated parameters to predict prognosis in chronic liver disease (CLD) patients. This study was conducted to determine as to how aspartate aminotransferase : platelet ratio index (APRI) fares in predicting adverse outcomes an… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles